Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker TRDA
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | MPM BioVentures 2018 GP LLC 10% owner | TRDA Entrada Therapeutics, Inc. | Sale | 28,837 | $7.13 | $205.6K Sale | Form 4 ↗ |
| Sep 9, 2026 | MPM Bioventures 2018 (B), L.P. 10% owner | TRDA Entrada Therapeutics, Inc. | Sale | 28,837 | $7.13 | $205.6K Sale | Form 4 ↗ |
| Sep 8, 2026 | MPM BioVentures 2018 GP LLC 10% owner | TRDA Entrada Therapeutics, Inc. | Sale | 192,500 | $7.41 | $1.4M Sale | Form 4 ↗ |
| Sep 8, 2026 | MPM Bioventures 2018 (B), L.P. 10% owner | TRDA Entrada Therapeutics, Inc. | Sale | 192,500 | $7.41 | $1.4M Sale | Form 4 ↗ |
| Sep 4, 2026 | MPM BioVentures 2018 GP LLC 10% owner | TRDA Entrada Therapeutics, Inc. | Sale | 38,500 | $7.11 | $273.7K Sale | Form 4 ↗ |
| Sep 4, 2026 | MPM Bioventures 2018 (B), L.P. 10% owner | TRDA Entrada Therapeutics, Inc. | Sale | 38,500 | $7.11 | $273.7K Sale | Form 4 ↗ |
| Sep 3, 2026 | MPM BioVentures 2018 LLC 10% owner | TRDA Entrada Therapeutics, Inc. | Sale | 32,263 | $7.17 | $231.3K Sale | Form 4 ↗ |
| Sep 3, 2026 | MPM BioVentures 2014 GP LLC 10% owner | TRDA Entrada Therapeutics, Inc. | Sale | 32,263 | $7.17 | $231.3K Sale | Form 4 ↗ |
| Sep 2, 2026 | MPM BioVentures 2018 LLC 10% owner | TRDA Entrada Therapeutics, Inc. | Sale | 25,131 | $7.19 | $180.7K Sale | Form 4 ↗ |
| Sep 2, 2026 | MPM BioVentures 2014 GP LLC 10% owner | TRDA Entrada Therapeutics, Inc. | Sale | 25,131 | $7.19 | $180.7K Sale | Form 4 ↗ |
| Sep 1, 2026 | MPM BioVentures 2018 LLC 10% owner | TRDA Entrada Therapeutics, Inc. | Sale | 29,088 | $7.06 | $205.4K Sale | Form 4 ↗ |
| Sep 1, 2026 | MPM BioVentures 2014 GP LLC 10% owner | TRDA Entrada Therapeutics, Inc. | Sale | 29,088 | $7.06 | $205.4K Sale | Form 4 ↗ |
| Aug 31, 2026 | MPM BioVentures 2018 LLC 10% owner | TRDA Entrada Therapeutics, Inc. | Sale | 44,259 | $6.99 | $309.4K Sale | Form 4 ↗ |
| Aug 31, 2026 | MPM BioVentures 2014 (B), L.P. 10% owner | TRDA Entrada Therapeutics, Inc. | Sale | 44,259 | $6.99 | $309.4K Sale | Form 4 ↗ |
| Aug 28, 2026 | MPM BioVentures 2018 LLC 10% owner | TRDA Entrada Therapeutics, Inc. | Sale | 3,733 | $7.01 | $26.2K Sale | Form 4 ↗ |
| Aug 28, 2026 | MPM BioVentures 2014 (B), L.P. 10% owner | TRDA Entrada Therapeutics, Inc. | Sale | 3,733 | $7.01 | $26.2K Sale | Form 4 ↗ |
| Aug 27, 2026 | MPM BioVentures 2018 LLC 10% owner | TRDA Entrada Therapeutics, Inc. | Sale | 38,922 | $7.20 | $280.2K Sale | Form 4 ↗ |
| Aug 27, 2026 | MPM BioVentures 2014 (B), L.P. 10% owner | TRDA Entrada Therapeutics, Inc. | Sale | 38,922 | $7.20 | $280.2K Sale | Form 4 ↗ |
| Aug 26, 2026 | Todd Foley 10% owner | TRDA Entrada Therapeutics, Inc. | Sale | 14,569 | $7.06 | $102.9K Sale | Form 4 ↗ |
| Aug 26, 2026 | MPM BioVentures 2018 LLC 10% owner | TRDA Entrada Therapeutics, Inc. | Sale | 14,569 | $7.06 | $102.9K Sale | Form 4 ↗ |
| Aug 25, 2026 | Todd Foley 10% owner | TRDA Entrada Therapeutics, Inc. | Sale | 26,522 | $7.54 | $200.0K Sale | Form 4 ↗ |
| Aug 25, 2026 | MPM BioVentures 2018 LLC 10% owner | TRDA Entrada Therapeutics, Inc. | Sale | 26,522 | $7.54 | $200.0K Sale | Form 4 ↗ |
| Aug 24, 2026 | Todd Foley 10% owner | TRDA Entrada Therapeutics, Inc. | Sale | 21,623 | $7.34 | $158.7K Sale | Form 4 ↗ |
| Aug 24, 2026 | MPM BioVentures 2018 LLC 10% owner | TRDA Entrada Therapeutics, Inc. | Sale | 21,623 | $7.34 | $158.7K Sale | Form 4 ↗ |
| Aug 10, 2026 | Kush Parmar Director | TRDA Entrada Therapeutics, Inc. | Sale | 92,444 | $7.00 | $647.1K Sale | Form 4 ↗ |
| Aug 7, 2026 | Kush Parmar Director | TRDA Entrada Therapeutics, Inc. | Sale | 52,317 | $6.85 | $358.4K Sale | Form 4 ↗ |
| Aug 7, 2026 | Scott M. Rocklage 10% owner | TRDA Entrada Therapeutics, Inc. | Sale | 52,317 | $6.85 | $358.4K Sale | Form 4 ↗ |
| Aug 6, 2026 | Kush Parmar Director | TRDA Entrada Therapeutics, Inc. | Sale | 10,494 | $7.00 | $73.5K Sale | Form 4 ↗ |
| Aug 6, 2026 | Scott M. Rocklage 10% owner | TRDA Entrada Therapeutics, Inc. | Sale | 10,494 | $7.00 | $73.5K Sale | Form 4 ↗ |
| Jul 31, 2026 | Kush Parmar Director, 10% owner | TRDA Entrada Therapeutics, Inc. | Sale | 1,718 | $6.85 | $11.8K Sale | Form 4 ↗ |
| Jul 31, 2026 | Scott M. Rocklage 10% owner | TRDA Entrada Therapeutics, Inc. | Sale | 1,718 | $6.85 | $11.8K Sale | Form 4 ↗ |
| Jul 30, 2026 | Kush Parmar Director, 10% owner | TRDA Entrada Therapeutics, Inc. | Sale | 114,756 | $6.93 | $795.3K Sale | Form 4 ↗ |
| Jul 30, 2026 | Scott M. Rocklage 10% owner | TRDA Entrada Therapeutics, Inc. | Sale | 114,756 | $6.93 | $795.3K Sale | Form 4 ↗ |
| May 20, 2026 | Bernhardt G. Zeiher Director | TRDA Entrada Therapeutics, Inc. | Buy | 5,000 | $5.86 | $29.3K Buy | Form 4 ↗ |
| May 4, 2026 | Natarajan Sethuraman President, Research & Develop. | TRDA Entrada Therapeutics, Inc. | Sale | 25,907 | $15.39 | $398.7K Sale | Form 4 ↗ |
| May 4, 2026 | Nathan J. Dowden President & COO | TRDA Entrada Therapeutics, Inc. | Sale | 15,000 | $15.33 | $229.9K Sale | Form 4 ↗ |
| Apr 1, 2026 | Kory James Wentworth Chief Financial Officer | TRDA Entrada Therapeutics, Inc. | Sale | 2,500 | $12.95 | $32.4K Sale | Form 4 ↗ |
| Mar 10, 2026 | Nathan J. Dowden President & COO | TRDA Entrada Therapeutics, Inc. | Sale | 11,894 | $13.05 | $155.2K Sale | Form 4 ↗ |
| Mar 10, 2026 | Kory James Wentworth Chief Financial Officer | TRDA Entrada Therapeutics, Inc. | Sale | 11,388 | $13.02 | $148.3K Sale | Form 4 ↗ |
| Mar 9, 2026 | Nathan J. Dowden President & COO | TRDA Entrada Therapeutics, Inc. | Sale | 3,116 | $13.02 | $40.6K Sale | Form 4 ↗ |
| Mar 9, 2026 | Kory James Wentworth Chief Financial Officer | TRDA Entrada Therapeutics, Inc. | Sale | 5,089 | $13.00 | $66.2K Sale | Form 4 ↗ |
| Mar 4, 2026 | Kory James Wentworth Chief Financial Officer | TRDA Entrada Therapeutics, Inc. | Sale | 7,988 | $12.25 | $97.9K Sale | Form 4 ↗ |
| Nov 21, 2025 | Kory James Wentworth Chief Financial Officer | TRDA Entrada Therapeutics, Inc. | Sale | 8,910 | $9.98 | $88.9K Sale | Form 4 ↗ |
| Nov 20, 2025 | Felix Baker 10% owner | TRDA Entrada Therapeutics, Inc. | Buy | 13,082 | $9.07 | $118.7K Buy | Form 4 ↗ |
| Nov 20, 2025 | Felix Baker 10% owner | TRDA Entrada Therapeutics, Inc. | Buy | 1,186 | $9.07 | $10.8K Buy | Form 4 ↗ |
| Nov 20, 2025 | Felix Baker 10% owner | TRDA Entrada Therapeutics, Inc. | Buy | 13,386 | $9.07 | $121.4K Buy | Form 4 ↗ |
| Nov 20, 2025 | Felix Baker 10% owner | TRDA Entrada Therapeutics, Inc. | Buy | 1,213 | $9.07 | $11.0K Buy | Form 4 ↗ |
| Nov 14, 2025 | Kush Parmar Director, 10% owner | TRDA Entrada Therapeutics, Inc. | Sale | 200,000 | $8.80 | $1.8M Sale | Form 4 ↗ |
| Nov 14, 2025 | 5AM Ventures V, L.P. 10% owner | TRDA Entrada Therapeutics, Inc. | Sale | 200,000 | $8.80 | $1.8M Sale | Form 4 ↗ |
| Nov 12, 2025 | Baker Bros. Advisors (GP) LLC 10% owner | TRDA Entrada Therapeutics, Inc. | Buy | 11,494 | $7.95 | $91.4K Buy | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 5:54 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances